Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
CHAPEL HILL, N.C. (AP) — GlaxoSmithKline and the University of North Carolina at Chapel Hill are teaming up to form a company which will look for a cure for AIDS.
Local media outlets report the two partners will form Qura Therapeutics, a Chapel Hill research company. The partnership also creates an HIV Cure center bringing together academic and pharmaceutical research scientists. The HIV Cure center housed in UNC's Marsico Hall will also be home to Qura.
Qura will be run by two board members, one from UNC and the other from GSK. There will not be a CEO.
GSK is contributing $20 million over five years to the project, while UNC is contributing physical lab space on its campus for several dozen scientists.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
